Tokyo, April 10 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061211) titled 'A Multicenter Observational Study on the Long-term Prognosis of Patients with Polycystic Kidney Disease' on April 9.
Study Type:
Observational
Primary Sponsor:
Institute - Tokyo Women's Medical University
Condition:
Condition - Polycystic Kidney Disease
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - This study is conducted as part of the Ministry of Health, Labour and Welfare's research program on "Intractable Kidney Diseases" and aims to identify risk factors associated with the long-term prognosis of patients with ADPKD, including renal outcomes, overall survival, ADPKD-related complications, and comorbidities.
Basic objectives2 - Others
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - 100
years-old
>=
Gender - Male and Female
Key inclusion criteria - Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD):
Patients who meet the diagnostic criteria for ADPKD as defined in the Polycystic Kidney Disease (PKD) Clinical Practice Guidelines 2020.
eGFR>=16mL/min/1.73m2
Key exclusion criteria - Patients receiving kidney replacement therapy (hemodialysis, peritoneal dialysis, or post-kidney transplantation)
Patients deemed unsuitable for inclusion in the study by the principal investigator for any other reason
Target Size - 3000
Recruitment Status:
Recruitment status - Open public recruiting
Date of protocol fixation - 2024 Year 09 Month 16 Day
Date of IRB - 2024 Year 10 Month 18 Day
Anticipated trial start date - 2024 Year 10 Month 18 Day
Last follow-up date - 2029 Year 06 Month 30 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070040
Disclaimer: Curated by HT Syndication.
